Europol actively apprehended nine suspects believed to be central to a cannabis investment Ponzi scheme that targeted over 186,000 victims. On April 11, a large-scale enforcement operation involving 400 law enforcement officers from 11 countries carried out 38 house searches. This well-coordinated effort led to the seizure or freezing of EUR 4.7 million in bank accounts, alongside over EUR 1.5 million in cryptocurrencies, EUR 106,000 in cash, and EUR 2.6 million in real estate assets.
Authorities also confiscated luxury vehicles, art pieces, cash reserves, and various high-end items during the raid. Additionally, a significant number of electronic devices and essential documents were recovered.
The fraudulent scheme centered around a cannabis cultivation crowdsourcing platform promoted on social networks between early 2020 and July 2022. While an estimated 550,000 individuals might have been affected globally, about 186,000 individuals actually invested funds or cryptocurrencies. Investors were lured into the scheme with the promise of a minimum entry-level investment of EUR 50 for access to the ‘e-growing’ venture, supposedly connecting them with medical cannabis producers. The platform assured investors, or e-growers, of profits from selling cannabis to authorized buyers after purchasing a cannabis plant.
Despite claims of annual returns exceeding 100%, the mechanism behind these promises remained undisclosed.
The suspects primarily consist of individuals of Russian nationality, with involvement from citizens of Dutch, German, Italian, Latvian, Maltese, Polish, Jordanian, American, and Venezuelan descent. This diverse composition illustrates the wide-reaching and international nature of the illegal operation.
Related on Weedly: Keep exploring the Weedly Glossary, our strain reviews, the Learn hub, our Canada coverage and our USA coverage.
Sources & further reading: For authoritative background see Health Canada, NIDA (US National Institute on Drug Abuse), the World Health Organization, Wikipedia and Leafly Learn.
The context: cannabis and investment fraud
The Europol operation against a medical marijuana investment scheme highlights a growing concern as the legal cannabis industry expands: fraud. The rapid rise of cannabis as a legitimate, high-profile industry has attracted not only genuine businesses and investors but also fraudsters who exploit the hype. Investment schemes promising outsized returns from cannabis ventures have appeared in various forms, sometimes operating as Ponzi structures that pay early investors with money from later ones until they collapse. As cannabis becomes a mainstream investment theme, understanding and guarding against such fraud has become increasingly important for investors across Europe and beyond.
Why cannabis attracts scams
Several factors make the cannabis sector a target for fraudulent schemes. The industry’s rapid growth and headline-grabbing success stories create an aura of easy money, while its relative novelty means many investors lack the knowledge to evaluate opportunities critically. The mix of genuine excitement, regulatory complexity and cross-border activity can obscure warning signs. Fraudsters exploit enthusiasm and the fear of missing out, promising guaranteed or unrealistic returns. This pattern is common in any booming industry, and cannabis, with its combination of hype and complexity, has proven especially susceptible to investment scams.
How Europol tackles cross-border crime
Europol, the European Union’s law-enforcement agency, coordinates cross-border investigations into serious and organized crime, including financial fraud that spans multiple countries. Cannabis-related schemes often operate internationally, making coordinated action essential. Europol’s role in supporting national authorities to dismantle such networks reflects the transnational nature of both the legal cannabis industry and the crime that can accompany it. Operations like this one demonstrate how European law enforcement adapts to emerging criminal trends tied to new industries, protecting investors and the integrity of the growing legal cannabis economy.
The legitimate medical cannabis industry
It is important to distinguish fraudulent schemes from the genuine, fast-growing legal medical cannabis industry in Europe. Legitimate medical cannabis businesses — cultivators, importers, pharmacies and product makers — operate under regulation across a growing number of European countries, serving real patients. The existence of fraud does not undermine the legitimacy of this sector; rather, it underscores the need for investors to distinguish credible, regulated businesses from opportunistic scams. The European medical cannabis market is a real and expanding economic opportunity, which is precisely why fraudsters try to exploit its reputation.
How investors can protect themselves
Investors interested in cannabis can protect themselves by exercising the same caution appropriate to any investment: be skeptical of guaranteed or unusually high returns, verify that companies and their claims are legitimate and properly regulated, seek independent advice, and avoid pressure to act quickly. Understanding the difference between speculative hype and sound business fundamentals is crucial in a sector prone to exaggeration. Due diligence, skepticism toward too-good-to-be-true promises, and reliance on regulated, transparent opportunities are the best defenses against the kind of scheme this operation targeted.
Learn more
For a broader look at the legitimate global cannabis market and its dynamics, see our guide to the global cannabis industry, and explore more on our International desk. Learn the key terms in our cannabis glossary. This case is a reminder that a legitimate, growing industry can attract illegitimate actors.
A sign of a maturing industry
Paradoxically, the appearance of fraud schemes is partly a sign that cannabis has matured into a serious, high-value industry. Scammers gravitate toward sectors where large sums are moving and public interest is high, and cannabis now qualifies on both counts. As the legal market has grown into a multibillion-dollar global industry, it has inevitably attracted the kind of financial crime seen around other booming sectors. Robust law enforcement, clearer regulation, and greater investor education are the tools that help a maturing industry weed out bad actors while protecting the legitimate businesses driving its growth.
The bottom line
The Europol operation against a medical marijuana investment scheme is a reminder that the fast-growing legal cannabis industry, for all its legitimate promise, also attracts fraud. Cannabis’s hype, novelty and cross-border nature make it a target for schemes promising unrealistic returns, and coordinated law enforcement is increasingly needed to combat them. Investors should exercise caution, distinguish genuine regulated businesses from scams, and apply rigorous due diligence. The legitimate medical cannabis sector remains real and growing — which is exactly why guarding against fraud matters. This article is informational and not financial advice; verify any opportunity independently.


